The global CAR T-cell therapy market is witnessing rapid growth, driven by increasing incidence of cancer and supportive regulatory approvals. Major players in the market are investing in development to expand their product portfolio and cater the growing requirement for effective cancer treatments. Additionally, advancements in CAR T-cell therapy